| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 81.72B | 80.39B | 79.24B | 77.65B | 71.89B | 69.69B |
| Gross Profit | 22.24B | 22.26B | 22.05B | 21.76B | 20.72B | 20.41B |
| EBITDA | 4.15B | 4.08B | 4.53B | 4.85B | 4.87B | 3.78B |
| Net Income | 870.00M | 958.60M | 1.30B | 1.51B | 1.62B | 850.20M |
Balance Sheet | ||||||
| Total Assets | 27.09B | 29.31B | 28.79B | 28.75B | 30.77B | 29.39B |
| Cash, Cash Equivalents and Short-Term Investments | 214.50M | 339.20M | 212.00M | 477.20M | 2.97B | 1.78B |
| Total Debt | 15.43B | 14.18B | 14.24B | 15.01B | 15.30B | 16.07B |
| Total Liabilities | 24.59B | 25.92B | 26.05B | 27.14B | 27.75B | 28.06B |
| Stockholders Equity | 2.50B | 3.39B | 2.75B | 1.61B | 3.02B | 1.32B |
Cash Flow | ||||||
| Free Cash Flow | 2.08B | 749.40M | 628.20M | 700.00M | 1.91B | 2.27B |
| Operating Cash Flow | 3.98B | 2.68B | 2.66B | 2.85B | 3.51B | 3.90B |
| Investing Cash Flow | -2.60B | -1.89B | -1.75B | -1.98B | -1.54B | -1.57B |
| Financing Cash Flow | -1.41B | -684.10M | -1.18B | -3.37B | -789.50M | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $7.19B | 15.05 | 38.21% | ― | 16.60% | 49.76% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $8.98B | 8.31 | 28.54% | 3.49% | 2.08% | -1.63% | |
60 Neutral | $1.77B | 11.86 | 5.93% | 0.93% | -5.42% | -20.80% | |
58 Neutral | $1.81B | 17.84 | 6.83% | 2.06% | 3.11% | 6.54% | |
55 Neutral | $43.09B | 40.33 | 13.04% | 2.15% | -1.77% | -70.83% | |
46 Neutral | $689.03M | -4.43 | -19.78% | ― | 7.22% | -108.99% |